Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biopharmaceutical Fermentation System Market Trends and Forecast
3.3: Global Biopharmaceutical Fermentation System Market by Product
3.3.1: Upstream Products
3.3.1.1: Fermenters
3.3.1.2: Bioprocess Analyzers
3.3.1.3: Process Monitoring Devices
3.3.1.4: Culture and Media Preparation
3.3.1.5: Culture Media
3.3.1.6: Buffers and Inducers
3.3.1.7: Other Upstream Products
3.3.2: Downstream Products
3.3.2.1: Filtration and Separation Systems
3.3.2.2: Chromatography
3.3.2.3: Consumables and Accessories
3.3.2.4: Other Downstream Products
3.4: Global Biopharmaceutical Fermentation System Market by Application
3.4.1: Recombinant Proteins
3.4.2: Monoclonal Antibodies
3.4.3: Antibiotics
3.4.4: Probiotics
3.5: Global Biopharmaceutical Fermentation System Market by End Use
3.5.1: Biopharmaceutical Companies
3.5.2: Contract Manufacturing Organizations
3.5.3: Contract Research Organizations
3.5.4: Academic Research Institutes
3.5.5: Food Industry
4. Market Trends and Forecast Analysis by Region
4.1: Global Biopharmaceutical Fermentation System Market by Region
4.2: North American Biopharmaceutical Fermentation System Market
4.2.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.2.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.2.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.2.4: The United States Biopharmaceutical Fermentation System Market
4.2.5: The Canadian Biopharmaceutical Fermentation System Market
4.2.6: The Mexican Biopharmaceutical Fermentation System Market
4.3: European Biopharmaceutical Fermentation System Market
4.3.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.3.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.3.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.3.4: The United Kingdom Biopharmaceutical Fermentation System Market
4.3.5: The Spanish Biopharmaceutical Fermentation System Market
4.3.6: The German Biopharmaceutical Fermentation System Market
4.3.7: The French Biopharmaceutical Fermentation System Market
4.4: APAC Biopharmaceutical Fermentation System Market
4.4.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.4.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.4.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.4.4: The Chinese Biopharmaceutical Fermentation System Market
4.4.5: The Indian Biopharmaceutical Fermentation System Market
4.4.6: The Japanese Biopharmaceutical Fermentation System Market
4.5: ROW Biopharmaceutical Fermentation System Market
4.5.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.5.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.5.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.5.4: Brazilian Biopharmaceutical Fermentation System Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Product
7.1.2: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Application
7.1.3: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by End Use
7.1.4: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Region
7.2: Emerging Trends in the Global Biopharmaceutical Fermentation System Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biopharmaceutical Fermentation System Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Fermentation System Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: GE Healthcare
8.2: Thermo Fisher Scientific
8.3: Danaher Corporation
8.4: Sartorius StedimBiotech
8.5: Merck
8.6: Eppendorf
8.7: Roche
8.8: Nova Biomedicals
8.9: Lonza
8.10: Becton Dickinson and Company